Horrell Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
FWCM
DLA
FFA
GI
CT
LJHT
BFA
GI
PNC
VCM
Horrell Capital Management's NVS Position: Q3 2026 in Review
Horrell Capital Management held its Novartis (NVS) position steady in Q3 2026 at 100 shares worth $14.3K. The position accounts for 0.01% of the portfolio, ranked #135.
Horrell Capital Management first reported a position in NVS in Q2 2013 and has held it in 24 quarters since. The position peaked at $54K in Q1 2015. 83 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Horrell Capital Management held 100 shares of Novartis worth $14.3K as of Q3 2026.
- Horrell Capital Management left its Novartis share count unchanged in Q3 2026.
- Novartis made up 0.01% of Horrell Capital Management's portfolio in Q3 2026, its #135 holding.
- Horrell Capital Management first reported a position in Novartis in Q2 2013 and has held it in 24 quarters since.
- Horrell Capital Management's Novartis position peaked at $54K in Q1 2015.
- 83 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Horrell Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.